Hidradenitis suppurativa

A comprehensive review

Ali Alikhan, Peter J. Lynch, Daniel B Eisen

Research output: Contribution to journalArticle

347 Citations (Scopus)

Abstract

Hidradenitis suppurativa, also known as acne inversa, is a chronic, often debilitating disease primarily affecting the axillae, perineum, and inframammary regions. Prevalence rates of up to 4% have been estimated. Our understanding of the disease has changed over time. It is now considered a disease of follicular occlusion rather than an inflammatory or infectious process of the apocrine glands. Clinically, the disease often presents with tender subcutaneous nodules beginning around puberty. The nodules may spontaneously rupture or coalesce, forming painful, deep dermal abscesses. Eventually, fibrosis and the formation of extensive sinus tracts may result. The location of the lesions may lead to social embarrassment and the failure to seek medical treatment. Therapies in the past have consisted of long-term antibiotics, antiandrogens, and surgery. New treatments like tumor necrosis factor-alfa inhibitors have given clinicians more options against this difficult disease. Learning objectives: After completing this learning activity, participants should be able to describe the clinical presentation, demographics, and prevalence of hidradenitis suppurativa, be familiar with current controversies regarding the pathogenesis of this complex, and be able to discuss potential treatments and their outcomes.

Original languageEnglish (US)
Pages (from-to)539-561
Number of pages23
JournalJournal of the American Academy of Dermatology
Volume60
Issue number4
DOIs
StatePublished - Apr 2009
Externally publishedYes

Fingerprint

Hidradenitis Suppurativa
Apocrine Glands
Learning
Androgen Antagonists
Perineum
Axilla
Puberty
Abscess
Rupture
Fibrosis
Tumor Necrosis Factor-alpha
Demography
Anti-Bacterial Agents
Skin

Keywords

  • acne inversa
  • etanercept
  • hidradenitis suppurativa
  • infliximab
  • Verneuil disease

ASJC Scopus subject areas

  • Dermatology

Cite this

Hidradenitis suppurativa : A comprehensive review. / Alikhan, Ali; Lynch, Peter J.; Eisen, Daniel B.

In: Journal of the American Academy of Dermatology, Vol. 60, No. 4, 04.2009, p. 539-561.

Research output: Contribution to journalArticle

Alikhan, Ali ; Lynch, Peter J. ; Eisen, Daniel B. / Hidradenitis suppurativa : A comprehensive review. In: Journal of the American Academy of Dermatology. 2009 ; Vol. 60, No. 4. pp. 539-561.
@article{eb0eabceb5c44a5c8b449797d9fa8c60,
title = "Hidradenitis suppurativa: A comprehensive review",
abstract = "Hidradenitis suppurativa, also known as acne inversa, is a chronic, often debilitating disease primarily affecting the axillae, perineum, and inframammary regions. Prevalence rates of up to 4{\%} have been estimated. Our understanding of the disease has changed over time. It is now considered a disease of follicular occlusion rather than an inflammatory or infectious process of the apocrine glands. Clinically, the disease often presents with tender subcutaneous nodules beginning around puberty. The nodules may spontaneously rupture or coalesce, forming painful, deep dermal abscesses. Eventually, fibrosis and the formation of extensive sinus tracts may result. The location of the lesions may lead to social embarrassment and the failure to seek medical treatment. Therapies in the past have consisted of long-term antibiotics, antiandrogens, and surgery. New treatments like tumor necrosis factor-alfa inhibitors have given clinicians more options against this difficult disease. Learning objectives: After completing this learning activity, participants should be able to describe the clinical presentation, demographics, and prevalence of hidradenitis suppurativa, be familiar with current controversies regarding the pathogenesis of this complex, and be able to discuss potential treatments and their outcomes.",
keywords = "acne inversa, etanercept, hidradenitis suppurativa, infliximab, Verneuil disease",
author = "Ali Alikhan and Lynch, {Peter J.} and Eisen, {Daniel B}",
year = "2009",
month = "4",
doi = "10.1016/j.jaad.2008.11.911",
language = "English (US)",
volume = "60",
pages = "539--561",
journal = "Journal of the American Academy of Dermatology",
issn = "0190-9622",
publisher = "Mosby Inc.",
number = "4",

}

TY - JOUR

T1 - Hidradenitis suppurativa

T2 - A comprehensive review

AU - Alikhan, Ali

AU - Lynch, Peter J.

AU - Eisen, Daniel B

PY - 2009/4

Y1 - 2009/4

N2 - Hidradenitis suppurativa, also known as acne inversa, is a chronic, often debilitating disease primarily affecting the axillae, perineum, and inframammary regions. Prevalence rates of up to 4% have been estimated. Our understanding of the disease has changed over time. It is now considered a disease of follicular occlusion rather than an inflammatory or infectious process of the apocrine glands. Clinically, the disease often presents with tender subcutaneous nodules beginning around puberty. The nodules may spontaneously rupture or coalesce, forming painful, deep dermal abscesses. Eventually, fibrosis and the formation of extensive sinus tracts may result. The location of the lesions may lead to social embarrassment and the failure to seek medical treatment. Therapies in the past have consisted of long-term antibiotics, antiandrogens, and surgery. New treatments like tumor necrosis factor-alfa inhibitors have given clinicians more options against this difficult disease. Learning objectives: After completing this learning activity, participants should be able to describe the clinical presentation, demographics, and prevalence of hidradenitis suppurativa, be familiar with current controversies regarding the pathogenesis of this complex, and be able to discuss potential treatments and their outcomes.

AB - Hidradenitis suppurativa, also known as acne inversa, is a chronic, often debilitating disease primarily affecting the axillae, perineum, and inframammary regions. Prevalence rates of up to 4% have been estimated. Our understanding of the disease has changed over time. It is now considered a disease of follicular occlusion rather than an inflammatory or infectious process of the apocrine glands. Clinically, the disease often presents with tender subcutaneous nodules beginning around puberty. The nodules may spontaneously rupture or coalesce, forming painful, deep dermal abscesses. Eventually, fibrosis and the formation of extensive sinus tracts may result. The location of the lesions may lead to social embarrassment and the failure to seek medical treatment. Therapies in the past have consisted of long-term antibiotics, antiandrogens, and surgery. New treatments like tumor necrosis factor-alfa inhibitors have given clinicians more options against this difficult disease. Learning objectives: After completing this learning activity, participants should be able to describe the clinical presentation, demographics, and prevalence of hidradenitis suppurativa, be familiar with current controversies regarding the pathogenesis of this complex, and be able to discuss potential treatments and their outcomes.

KW - acne inversa

KW - etanercept

KW - hidradenitis suppurativa

KW - infliximab

KW - Verneuil disease

UR - http://www.scopus.com/inward/record.url?scp=61849173997&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=61849173997&partnerID=8YFLogxK

U2 - 10.1016/j.jaad.2008.11.911

DO - 10.1016/j.jaad.2008.11.911

M3 - Article

VL - 60

SP - 539

EP - 561

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

SN - 0190-9622

IS - 4

ER -